The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Collegium Pharmaceutical Inc shares valued at $757,380 were purchased by Heffernan Michael Thomas on Jul 02 ’25. At $30.30 per share, Heffernan Michael Thomas acquired 25,000 shares.
Also, Melincoff Gwen A purchased 47,082 shares, netting a total of over 1,425,971 in proceeds.
Before that, Freund John Gordon had sold 6,601 shares from its account. In a trade valued at $202,149, the Director traded Collegium Pharmaceutical Inc shares for $30.62 each. Upon closing the transaction, the insider’s holdings decreased to 6,601 shares, worth approximately $2.14 million.
As published in a research note from Needham on January 10, 2025, Collegium Pharmaceutical Inc [COLL] has been rated up from a Hold to a Buy and the price target has been revised to $46. Analysts at H.C. Wainwright upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in late July. As of June 07, 2024, Jefferies has increased its “Hold” rating to a “Buy” for COLL. Earlier on May 10, 2024, Piper Sandler downgraded its rating. Their new recommendation was “a Neutral” for COLL stock which previously was a “an Overweight”.
Analyzing COLL Stock Performance
On last trading session, Collegium Pharmaceutical Inc [NASDAQ: COLL] plunged -0.52% to $30.35. The stock’s lowest price that day was $29.82, but it reached a high of $30.92 in the same session. During the last five days, there has been a surge of approximately 1.51%. Over the course of the year, Collegium Pharmaceutical Inc shares have dropped approximately -6.96%. Shares of the company reached a 52-week high of $34.06 on 01/10/25 and a 52-week low of $23.23 on 04/10/25.
Support And Resistance Levels for Collegium Pharmaceutical Inc (COLL)
According to the 24-hour chart, there is a support level at 29.81, which, if violated, would cause prices to drop to 29.26. In the upper region, resistance lies at 30.91. The next price resistance is at 31.46. RSI (Relative Strength Index) is 58.36 on the 14-day chart, showing neutral technical sentiment.
Is Collegium Pharmaceutical Inc subject to short interest?
Stocks of Collegium Pharmaceutical Inc saw a sharp steep in short interest on 2025-06-13 dropping by -0.26 million shares to 4.82 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 5.08 million shares. A decline of -5.4% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 17.76 of the overall float, the days-to-cover ratio (short ratio) decline to 17.76.
Which companies own the most shares of Collegium Pharmaceutical Inc (COLL)?
In terms of Collegium Pharmaceutical Inc share price expectations, FactSet research, analysts set an average price target of 36 in the next 12 months, up nearly 17.99% from the previous closing price of $30.51. Analysts anticipate Collegium Pharmaceutical Inc stock to reach 36 by 2025, with the lowest price target being 36. In spite of this, 4 analysts ranked Collegium Pharmaceutical Inc stock as Buy at the end of 2025.
